NanoViricides, Inc.
Public
SectorHealthcare
CountryUnited States
Market cap26.02M
NanoViricides, Inc.: A clinical-stage biopharmaceutical company focused on developing nanotechnology-based antiviral therapies that target and dismantle specific viral threats.
